Literature DB >> 475655

Reversible compression neuropathy of the eighth cranial nerve from a large jugular foramen schwannoma.

J G Neely.   

Abstract

Jugular foramen schwannomas are unusual tumors occasionally resulting in neural hearing losses. Two previously reported cases document preservation of hearing following removal of a jugular foramen schwannoma. I report the third such case, in which there was progressive auditory and vestibular dysfunction seen on serial preoperative auditory tests and recovery of function seen on postoperative auditory and vestibular tests. The presumed pathophysiologic feature sub-serving this observation is compression neuropathy. I discuss experiences with compression neuropathy in animals and man under other circumstances.

Entities:  

Mesh:

Year:  1979        PMID: 475655     DOI: 10.1001/archotol.1979.00790210053012

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  6 in total

1.  Glossopharyngeal nerve schwannoma: report of a case operated on by the far-lateral transcondylar approach.

Authors:  F Puzzilli; L Mastronardi; U Agrillo; P Nardi
Journal:  Skull Base Surg       Date:  1999

2.  Twelve cases of jugular foramen neurinoma.

Authors:  S Tomio; K Takakura
Journal:  Skull Base Surg       Date:  1991

3.  Jugular foramen schwannomas: surgical approaches and outcome of treatment.

Authors:  H Yoo; H W Jung; H J Yang
Journal:  Skull Base Surg       Date:  1999

4.  Extirpation of a jugular foramen schwannoma via the transcervical-transmandibular approach.

Authors:  L Saydam; D T Donovan
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 5.  Dumbbell-shaped jugular foramen schwannoma.

Authors:  M Takahashi; T Adachi; K Sako
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

6.  Dumbbell-shaped jugular foramen schwannomas: surgical management, outcome and complications on a series of 16 patients.

Authors:  S Chibbaro; G Mirone; O Makiese; D Bresson; B George
Journal:  Neurosurg Rev       Date:  2009-02-03       Impact factor: 3.042

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.